This dose of anti-VEGFR showed a smaller inhibitory effect on tumor progression (Supplementary Fig. 5A) than that of the full therapeutic dose but still had a tumor inhibitory effect that the tumor weight was lighter than that of the control IgG group at 19 days when tumors were collected for flow cytometry analyses (Supplementary Fig. 5B). Here, KDR is linked to neoplasm.